According to the American Cancer Society, about one in six men will develop prostate cancer in their lifetime. However, in the past 20 years, the survival rate for all stages of prostate cancer has risen from 67 percent to 93 percent.

Treatment options for prostate cancer vary, and depend upon the health, age and preferences of the patient, as well as the stage of the tumor. One such option, the complete removal of the prostate along with some surrounding tissue, is called a radical prostatectomy.

Crozer-Keystone Health System offers prostate cancer patients the option of removal of the prostate with the use of robotic surgery via the FDA approved da Vinci Surgical System. Surgeons from Springfield Hospital demonstrated and discussed the use of robotic surgery in the treatment of prostate cancer during a Webcast.

David Samadi, MD, Chief, Division of Robotics and Minimally Invasive Surgery, Mount Sinai Medical Center, New York and Crozer-Keystone consultant, performed a robotic-assisted prostatectomy and Dr. James O'Connell assisted. Dr. Frank D'Ellia and Dr. Ilya Volfson moderated the event.

To request more information, make an appointment, or make a referral, click on the link below.

Robotic Assisted Prostatectomy
Webcast Home Page